NTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nutrien Ltd (NTR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and favorable market conditions for fertilizers due to geopolitical disruptions make it a compelling investment opportunity.
The MACD histogram is negative (-0.318) but contracting, indicating a potential reversal. RSI is neutral at 50.542, suggesting no overbought or oversold conditions. Moving averages are converging, showing indecision in the market. The stock is trading near its pivot level of 74.425, with key resistance at 77.263 and support at 71.587.
Analysts have raised price targets significantly, with multiple firms maintaining Outperform or Overweight ratings.
Geopolitical disruptions in the Middle East have tightened fertilizer supply, leading to higher nitrogen and phosphate prices.
Strong financial performance in Q4 2025, with revenue up 5.14% YoY, net income up 405.31% YoY, and EPS up 413.04% YoY.
Hedge funds are selling, with a 116.85% increase in selling activity over the last quarter.
UBS downgraded the stock to Sell, citing potential pricing declines in potash later in the decade.
Technical indicators show no strong bullish momentum currently.
Nutrien reported robust financials in Q4 2025, with revenue increasing by 5.14% YoY to $5.34 billion, net income surging by 405.31% YoY to $571 million, and EPS growing by 413.04% YoY to 1.18. Gross margin improved to 35.36%, up 13.59% YoY, reflecting strong operational efficiency.
Analyst sentiment is predominantly positive, with multiple firms raising price targets (e.g., Morgan Stanley to $93, RBC to $85, Wells Fargo to $100) and maintaining Outperform or Overweight ratings. However, UBS downgraded the stock to Sell, citing long-term risks in potash pricing.
